Inhibition of GEF Vav2, by its pharmacological inhibitor EHop, prevents activation of Rac1-Nox2-ROS signaling and inhibits mitochondrial damage and the development of retinopathy in diabetic mice [50]. Here, CYBB is linked to retinal disorder.